MedPath

National Eye Institute

National Eye Institute logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1968-01-01
Employees
101
Market Cap
-
Website
http://www.nei.nih.gov

Color Vision as a Measure for Inherited Retinal Diseases

Completed
Conditions
Healthy Volunteer
Retinal Disease
Inherited Retinal Degeneration
First Posted Date
2013-06-14
Last Posted Date
2017-10-06
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
166
Registration Number
NCT01878032
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Intestinal Bacteria and Ocular Inflammatory Disease

Completed
Conditions
Uveitis
First Posted Date
2013-05-21
Last Posted Date
2025-05-20
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
131
Registration Number
NCT01859299
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Nitisinone for Type 1B Oculocutaneous Albinism

Phase 1
Completed
Conditions
Albinism
Vision Loss
Interventions
First Posted Date
2013-04-24
Last Posted Date
2019-02-26
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
5
Registration Number
NCT01838655
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Gevokizumab for Active Scleritis

Phase 1
Completed
Conditions
Scleritis
Interventions
Device: Gevokizumab
First Posted Date
2013-04-18
Last Posted Date
2018-07-06
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
8
Registration Number
NCT01835132
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

AMD Phenotype and Genotype Study

Completed
Conditions
AMD
Age-Related Macular Degeneration
First Posted Date
2013-01-29
Last Posted Date
2018-04-05
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
344
Registration Number
NCT01778491
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

🇩🇪

University of Bonn, Bonn, Germany

Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)

Recruiting
Conditions
Anophthalmia
Coloboma
Microphthalmia
First Posted Date
2013-01-29
Last Posted Date
2025-05-18
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
600
Registration Number
NCT01778543
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Natural History of Eye Diseases Related to ABCA4 Mutations

Active, not recruiting
Conditions
ABCA4-Related Retinopathies
Retinal Degeneration
First Posted Date
2012-11-29
Last Posted Date
2025-05-20
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
68
Registration Number
NCT01736293
Locations
🇺🇸

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy

Phase 2
Terminated
Conditions
Geographic Atrophy
Interventions
First Posted Date
2012-08-30
Last Posted Date
2015-12-10
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
52
Registration Number
NCT01675947
Locations
🇺🇸

University of Florida HSC, Jacksonville, Florida, United States

🇺🇸

Vision Research Foundation, Grand Rapids, Michigan, United States

🇺🇸

Elman Retina Group, Baltimore, Maryland, United States

and more 10 locations

CNTF Implants for CNGB3 Achromatopsia

Phase 1
Completed
Conditions
Eye Disease
Achromatopsia
Interventions
Biological: NT-501 CNTF-releasing implant
First Posted Date
2012-07-24
Last Posted Date
2016-11-21
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
5
Registration Number
NCT01648452
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Ustekinumab for Active Sight-Threatening Uveitis

Phase 1
Withdrawn
Conditions
Uveitis
First Posted Date
2012-07-20
Last Posted Date
2019-12-05
Lead Sponsor
National Eye Institute (NEI)
Registration Number
NCT01647152
© Copyright 2025. All Rights Reserved by MedPath